Summary: <br> <a href="https://twitter.com/intent/tweet?url=http%3A%2F%2Fwww.talkingbiotechpodcast.com%2F227-anti-crisprs%2F&via=talkingbiotech" class="twitter-share-button" data-size="large">Tweet</a><br> <a href="https://i0.wp.com/www.talkingbiotechpodcast.com/wp-content/uploads/2020/02/227-bondyD-cover.png"></a><br> The gene editing explosion has accelerated discovery, food and therapies by defining a new toolbox of useful ways to manipulate DNA. The “Cas” series of enzymes are the core machinery of the editing process, and now scientists are identifying new molecules that inhibit these molecular scissors. Dr. Joseph Bondy-Denomy rides at the front edge of this discovery, and his program is characterizing the naturally-occurring factors in a bacteria/virus arms race that play a role in modulating Cas activity.<br> Follow Dr. Bondy-Denomy on Twitter: <a href="https://twitter.com/joeBondyDenomy">@joebondydenomy</a><br> The Bondy-Denomy Lab website: <a href="https://bondydenomylab.ucsf.edu/">Here.</a><br> <br> Conclusion music is Sleepwalk by Santo and Johnny, 1959.<br>
